GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,431 | +96.7% | 8,037 | +47.5% | 0.00% | – |
| Q2 2023 | $7,846 | -85.7% | 5,449 | -79.2% | 0.00% | – |
| Q1 2023 | $54,974 | +659.1% | 26,178 | +308.5% | 0.00% | – |
| Q4 2022 | $7,242 | -44.3% | 6,409 | -24.8% | 0.00% | – |
| Q3 2022 | $13,000 | +18.2% | 8,522 | -0.1% | 0.00% | – |
| Q2 2022 | $11,000 | -15.4% | 8,528 | +0.3% | 0.00% | – |
| Q1 2022 | $13,000 | -27.8% | 8,504 | +0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -45.5% | 8,503 | +0.1% | 0.00% | – |
| Q3 2021 | $33,000 | -15.4% | 8,497 | -29.4% | 0.00% | – |
| Q2 2021 | $39,000 | -13.3% | 12,040 | -40.8% | 0.00% | – |
| Q1 2021 | $45,000 | -79.3% | 20,328 | -79.0% | 0.00% | – |
| Q4 2020 | $217,000 | +41.8% | 96,815 | +69.1% | 0.00% | – |
| Q3 2020 | $153,000 | -26.8% | 57,244 | -15.8% | 0.00% | – |
| Q2 2020 | $209,000 | +134.8% | 67,946 | +48.8% | 0.00% | – |
| Q1 2020 | $89,000 | -1.1% | 45,658 | +45.1% | 0.00% | – |
| Q4 2019 | $90,000 | -15.1% | 31,470 | +9.4% | 0.00% | – |
| Q3 2019 | $106,000 | +278.6% | 28,762 | +327.1% | 0.00% | – |
| Q2 2019 | $28,000 | -17.6% | 6,734 | +3.7% | 0.00% | – |
| Q1 2019 | $34,000 | +13.3% | 6,492 | -24.8% | 0.00% | – |
| Q4 2018 | $30,000 | -91.5% | 8,629 | -85.2% | 0.00% | – |
| Q3 2018 | $352,000 | +38.0% | 58,471 | +45.7% | 0.00% | – |
| Q2 2018 | $255,000 | +410.0% | 40,135 | +279.3% | 0.00% | – |
| Q1 2018 | $50,000 | +38.9% | 10,582 | -2.8% | 0.00% | – |
| Q4 2017 | $36,000 | +44.0% | 10,882 | -8.4% | 0.00% | – |
| Q3 2017 | $25,000 | -16.7% | 11,882 | 0.0% | 0.00% | – |
| Q2 2017 | $30,000 | +11.1% | 11,882 | 0.0% | 0.00% | – |
| Q1 2017 | $27,000 | +575.0% | 11,882 | +151.7% | 0.00% | – |
| Q4 2016 | $4,000 | -20.0% | 4,720 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | -16.7% | 4,720 | +26.9% | 0.00% | – |
| Q2 2016 | $6,000 | 0.0% | 3,720 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | 0.0% | 3,720 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | -45.5% | 3,720 | -18.2% | 0.00% | – |
| Q3 2015 | $11,000 | -45.0% | 4,550 | -37.5% | 0.00% | – |
| Q2 2015 | $20,000 | -37.5% | 7,285 | -24.1% | 0.00% | – |
| Q1 2015 | $32,000 | +100.0% | 9,592 | +115.3% | 0.00% | – |
| Q4 2014 | $16,000 | -27.3% | 4,456 | +1.9% | 0.00% | – |
| Q3 2014 | $22,000 | -72.8% | 4,373 | -25.6% | 0.00% | – |
| Q2 2014 | $81,000 | -38.6% | 5,881 | -31.9% | 0.00% | – |
| Q1 2014 | $132,000 | +676.5% | 8,636 | +307.4% | 0.00% | – |
| Q4 2013 | $17,000 | -19.0% | 2,120 | 0.0% | 0.00% | – |
| Q3 2013 | $21,000 | – | 2,120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |